Jump to content

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients (Q40338985)

From Wikidata
scientific article published on December 2005
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
    scientific article published on December 2005

      Statements

      Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients (English)
      Thomas Januario
      David A Eberhard
      Somasekar Seshagiri
      Vincent O'Neill

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit